BackInterCure Overview

InterCure Receivables

Track InterCure's receivables ($150M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$154.47M
14.42% YoYΔ $-26.03M vs prior year quarter

Peer trimmed avg / median

Loading

InterCure Receivables History

Loading

InterCure vs. peers: Receivables Comparison

Loading

InterCure Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

InterCure (IRCLF) FAQ

The latest receivables for IRCLF is $150M as of December 2025. That compares with $180M in the prior-year period — down 14.4% year over year. Investors often review this figure alongside InterCure's historical trend and sector peers before judging valuation or financial health.

Over the past year, IRCLF's receivables moved from $180M to $150M — a 14.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in InterCure's operating scale or balance-sheet position.

A receivables figure of $150M for IRCLF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IRCLF's receivables ($150M), review year-over-year change from $180M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack InterCure's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.